These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36941538)
1. Seven bacterial response-related genes are biomarkers for colon cancer. Xiong Z; Li W; Luo X; Lin Y; Huang W; Zhang S BMC Bioinformatics; 2023 Mar; 24(1):103. PubMed ID: 36941538 [TBL] [Abstract][Full Text] [Related]
2. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer. Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257 [TBL] [Abstract][Full Text] [Related]
5. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. Huang W; Liu Z; Li Y; Liu L; Mai G J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis. Zhou Y; Guo Y; Wang Y IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485 [TBL] [Abstract][Full Text] [Related]
7. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
9. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
10. Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma. Zhou W; Zhang S; Li HB; Cai Z; Tang S; Chen LX; Lang JY; Chen Z; Chen XL Biomed Res Int; 2020; 2020():9807918. PubMed ID: 32964050 [TBL] [Abstract][Full Text] [Related]
11. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma. Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269 [TBL] [Abstract][Full Text] [Related]
12. Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs. Hao Z; Liang P; He C; Sha S; Yang Z; Liu Y; Shi J; Zhu Z; Chang Q BMC Bioinformatics; 2022 Oct; 23(1):435. PubMed ID: 36258178 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C Front Immunol; 2021; 12():783362. PubMed ID: 35154072 [TBL] [Abstract][Full Text] [Related]
14. A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma. Fu X; Duanmu J; Li T; Jiang Q PeerJ; 2020; 8():e8877. PubMed ID: 32309045 [TBL] [Abstract][Full Text] [Related]
15. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
16. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma. Li H; Liu L; Huang T; Jin M; Zheng Z; Zhang H; Ye M; Liu K Aging (Albany NY); 2021 Oct; 13(19):23072-23095. PubMed ID: 34610581 [TBL] [Abstract][Full Text] [Related]
17. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer. Xu M; Li Q; Zhang J; Xie H Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646 [TBL] [Abstract][Full Text] [Related]
18. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Yan C; Niu Y; Li F; Zhao W; Ma L J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146 [TBL] [Abstract][Full Text] [Related]
19. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer. Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z Front Immunol; 2022; 13():951455. PubMed ID: 36189298 [TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]